Insider Trading & Ownership - Piper Brian

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Piper Brian
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-08-25
Sale
2021-08-27
8:02 pm
Prelude Therapeutics IncPRLDPiper Brian
Chief Financial Officer
8,333$33.34$277,827264,329
(Direct)
View
2021-05-25
Sale
2021-05-27
5:03 pm
Prelude Therapeutics IncPRLDPiper Brian
Chief Financial Officer
8,333$34.27$285,537272,662
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-08-25
Exercise
2021-08-27
8:02 pm
N/A
2029-08-06
Prelude Therapeutics IncPRLDPiper Brian
Chief Financial Officer
8,333$0264,329
(Direct)
View
2021-08-25
Exercise
2021-08-27
8:02 pm
N/A
N/A
Prelude Therapeutics IncPRLDPiper Brian
Chief Financial Officer
8,333$1.89264,329
(Direct)
View
2021-07-20
Option Award
2021-07-22
6:09 pm
N/A
2031-07-19
Prelude Therapeutics IncPRLDPiper Brian
Chief Financial Officer
115,650$0115,650
(Direct)
View
2021-05-25
Exercise
2021-05-27
5:03 pm
N/A
2029-08-06
Prelude Therapeutics IncPRLDPiper Brian
Chief Financial Officer
8,333$0272,662
(Direct)
View
2021-05-25
Exercise
2021-05-27
5:03 pm
N/A
N/A
Prelude Therapeutics IncPRLDPiper Brian
Chief Financial Officer
8,333$1.89272,662
(Direct)
View

Ownership
2020-09-24
7:27 pm
N/A
2029-08-06
Prelude Therapeutics IncPRLDPiper Brian
Chief Financial Officer
0$0462,559
(Direct)
View